Dr. Broyles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
515 Minor Ave
Ste 300
Seattle, WA 98104Phone+1 206-386-9500Fax+1 206-386-9605
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1992
Texas Health Resources (Dallas)Residency, Internal Medicine, 1987 - 1990
Albany Medical CenterInternship, Internal Medicine, 1984 - 1985
University of Florida College of MedicineClass of 1984
Certifications & Licensure
WA State Medical License 1990 - 2025
TX State Medical License 1986 - 1991- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Top MD Consumers Checkbook
Clinical Trials
- Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Start of enrollment: 2013 Jun 10
- An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Start of enrollment: 2014 May 23
Publications & Presentations
PubMed
- 2 citationsDiagnosis of Cushing's disease in a patient with consistently normal urinary free cortisol levels: a case report.Kelley J. Moloney, Jennifer U. Mercado, William H. Ludlam, Frances E. Broyles
Clinical Case Reports. 2016-11-09 - 37 citationsComparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.Robert H. Knopp, Frances E. Broyles, Marian Cheung, Katherine H. Moore, Santica M. Marcovina
Contraception. 2001-01-01 - 5 citationsEffect of Pravastatin in the Treatment of Patients with Type III Hyperlipoproteinemia.Robert H. Knopp, D. Roger Illingworth, Evan A. Stein, Henry N. Ginsberg, Frances E. Broyles
American Journal of Therapeutics. 1996-11-01
Press Mentions
High-Frequency Spinal Cord Stimulator Gets FDA NodJuly 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
